Steve Chilinski, CEO of PharmaLogic, and various team members cut the ceremonial ribbon to signify the opening of PharmaLogic NYC.
PharmaLogic Announces Opening of Radiopharmaceutical Production Facility in New York City
Acquired in 2022, the facility has undergone extensive renovations and boasts state-of-the-art equipment, signifying the companys significant investment in fostering the development of novel radiopharmaceuticals in the region.